UBIC's Advanced Forensic Tool Supports Third-Party Investigation

UBIC's Advanced Forensic Tool Supports Third-Party Investigation

High-Level Analysis Support Solutions Service Delivering Results as Big Data
Analysis Grows in Importance

TOKYO, June 24, 2014 (GLOBE NEWSWIRE) -- UBIC, Inc. (Nasdaq:UBIC) (TSE:2158),
a leading provider of international litigation support and big-data analysis
services, announced today the achievements of its new high-level analysis
support solutions service for third-party investigation charged with
investigating corporate fraud and other cases of inappropriate practices in
Japan. UBIC is cited by reports issued by two major pharmaceutical
manufacturers, Takeda Pharmaceutical Co. Ltd. and Novartis Pharma K.K., whose
third-party investigations used UBIC's analysis support solutions, which take
advantage of the company's evidentiary document analytics and review platform,
Lit i View®.

The investigation results as described in Takeda's third-party investigation
report published on June 20 show that the new analysis support service
provides an efficient and effective alternative option to the human review of
electronic data in e-discovery work.

Usually, third-party investigations which have been set up to investigate a
fraud case, for example, would engage a digital forensic service vendor to
identify and collect potential evidence from the corporation's electronic data
stores and put a team of lawyers to work examining the selected data in more
detail. This process requires a great deal of time, manpower and money. UBIC's
new service can substantially reduce the time, labor and cost of investigation
by simplifying and speeding up this process. UBIC provides investigators with
access to an artificial intelligence (AI)-based evidence analysis system, via
the cloud, that can perform functions including personal network analysis and
Asian-language keyword search very quickly and accurately. UBIC also provides
services to train investigating lawyers to operate the system and to support

Novartis Pharma K.K.'s third-party investigation report, published on April 2,
also includes findings that highlight the excellence of UBIC's high-level
analysis support solutions service.

These reports highlight the reliability of UBIC's solutions service, as well
as our technological prowess.

High-level analysis solutions are becoming increasingly essential not only in
investigations by third-party investigation but also in criminal
investigations by law enforcement authorities. As a pioneer of information
analysis solutions using "behavior informatics" – which refers to the science
of analyzing electronic data as a collection of thinking and behavior patterns
of humans - UBIC will continue to pursue advancements in R&D and contribute to
the creation of a better and safer society.

About UBIC

UBIC, Inc. (Nasdaq:UBIC) (TSE:2158) is a leading provider of e-discovery and
digital forensic services for Asia and the world. UBIC has extensive
experience working with electronically stored information composed in Chinese,
Japanese and Korean (CJK) languages and utilizes that expertise for clients
involved in cross-border litigation, corporate investigations, intellectual
property disputes and much more. At the forefront of e-discovery innovation,
UBIC's proprietary Lit i View^® platform is moving the industry from "fact
discovery" to "future discovery" by allowing clients to analyze e-mail
messages and digital communications found in big data to reveal patterns in
human thought and behavior.

For more information about UBIC, contact us info@ubicna.com or visit

CONTACT: Masatoshi Ohno
         UBIC North America, Inc.
         Email: masatoshi_ohno@ubic.co.jp
         Sasha Hefler
         UBIC North America, Inc.
         Tel: (650) 868-2623

Press spacebar to pause and continue. Press esc to stop.